Multi-center Cross-sectional Epidemiological Study to Characterize the Prevalence and Distribution of Lipoprotein(a) Levels Among Patients With Established Cardiovascular Disease
Objective
The primary objective of this trial is to improve knowledge about the epidemiology of Lipoprotein(a) in patients with established cardiovascular disease (CVD).
Eligibility
Established CVD defined as one of the following:
- History of a myocardial infarction (MI) ≥3 months and ≤10 years before the study visit
- History of ischemic stroke ≥ 3 months and ≤ 10 years before the study visit
- Symptomatic PAD (intermitted claudication with ankle-brachial index ≤0.90 and/or lower limb amputation or re-vascularization due to lower limb ischemia
